Insulin resistance and β‐cell dysfunction in normoglycaemic European women with a history of gestational diabetes
- 14 August 2003
- journal article
- website
- Published by Wiley in Clinical Endocrinology
- Vol. 59 (3) , 289-297
Abstract
Summary: objective Women with previous gestational diabetes (GDM) are at increased risk of subsequent type 2 diabetes. To characterize early metabolic abnormalities associated with this increased risk, we studied normoglycaemic women with a history of GDM.patients and measurements We performed an insulin‐modified, frequently sampled intravenous glucose tolerance test (FSIVGTT) in 34 normoglycaemic European women with previous GDM and 44 European control women, deriving measures of insulin sensitivity, glucose effectiveness, glucose disappearance rate and acute insulin response to glucose.results Post‐GDM women were more obese than controls [body mass index (BMI), geometric mean (95% confidence interval); 25·3 kg/m2 (23·8–27·1 kg/m2) vs. 23·1 kg/m2 (21·9–24·3 kg/m2), P = 0·03]. Evidence of insulin resistance was provided by their lower insulin sensitivity as measured by FSIVGTT [0·6 × 10−4/min/pmol/l (0·3–1·2 × 10−4/min/pmol/l) vs. 1·5 × 10−4/min/pmol/l (1·2–1·8 × 10−4/min/pmol/l), P = 0·01] and by homeostatic model assessment [72% (49–107%) vs. 153% (113–206%), P = 0·004]; and by their higher fasting triglycerides [1·0 mmol/l (0·7–1·5 mmol/l) vs. 0·7 mmol/l (0·6–0·8 mmol/l), P = 0·001]. Though there was no difference between groups in fasting NEFA levels, acute NEFA suppression was diminished in the post‐GDM group (P = 0·01). Concomitant β‐cell dysfunction in the post‐GDM women was revealed by their lower disposition index [0·05/min (0·02–0·10/min) vs. 0·11/min (0·09–0·14/min), P = 0·02] compared to controls. The differences in insulin sensitivity, but not those of β‐cell function, were partly, though not completely, attributable to differences in regional and total adiposity.conclusions European normoglycaemic women with previous GDM display both glucoregulatory and antilipolytic insulin resistance, reduced β‐cell function and dyslipidaemia. These metabolic abnormalities are likely to contribute to their increased risk of future type 2 diabetes.Keywords
This publication has 46 references indexed in Scilit:
- Prevalence and features of pancreatic islet cell autoimmunity in women with gestational diabetes from different ethnic groupsBritish Journal of Obstetrics and Gynaecology, 2001
- Prevalence and features of pancreatic islet cell autoimmunity in women with gestational diabetes from different ethnic groupsBJOG: An International Journal of Obstetrics & Gynaecology, 2001
- Pronounced Insulin Resistance and Inadequate β-cell Secretion Characterize Lean Gestational Diabetes During and After PregnancyDiabetes Care, 1997
- A Longitudinal Study of Plasma Insulin and Glucagon in Women With Previous Gestational DiabetesDiabetes Care, 1995
- Insulin Resistance with Respect to Lipolysis in Non‐diabetic Relatives of European Patients with Type 2 DiabetesDiabetic Medicine, 1995
- Gestational Diabetes and Follow‐up Among Immigrant Vietnam‐born WomenAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1993
- Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up studyThe Lancet, 1992
- Measurement of Insulin Secretion in Type 2 Diabetes: Problems and PitfallsDiabetic Medicine, 1992
- Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.Journal of Clinical Investigation, 1987